Key Highlights

  • Norwood Systems reported customer receipts of A$808,000, up 38%, and a net operating cash inflow of A$103,000.
  • XPON Technologies completed the Datisan sale for $8.1 million of initial cash and repaid its $800k loan on 1 October 2026.
  • Audeara's group revenue rose 37.7% to $656,747 and its first two AI noise reduction licensing programs entered production.
  • Quarter-end cash was A$14,000 at Norwood, $8.412 million at XPON and $247k at Audeara.

Three ASX-listed technology companies filed Appendix 4C reports for the quarter ended 30 September 2026, each showing a different cash position. Norwood Systems Ltd (ASX:NOR) recorded a net operating cash inflow of A$103,000 on customer receipts of A$808,000. XPON Technologies Group Ltd (ASX:XPN) completed the sale of Datisan Pty Ltd for $8.1 million in initial cash consideration. Audeara Ltd (ASX:AUA) reported group revenue of $656,747, up 37.7% on the June quarter, and moved its first two AI noise reduction licensing programs into commercial production.

Norwood Systems: Receipts Up 38% as Tier-1 Talks Continue

Norwood's customer receipts rose by A$224,000 from A$584,000 in the June quarter. Government grants and tax incentives contributed A$657,000, and operating payments totalled A$1.362 million, which left the A$103,000 inflow against an A$222,000 outflow a quarter earlier. Net financing outflow was A$265,000, and cash closed at A$14,000, down from A$176,000. Research and development was the largest payment line at A$538,000, followed by staff costs of A$350,000.

Operator engagements continued across three regions. A A$200,000 Microsoft-contracted OpenSpan pilot in Australia was completed in the first half of July, a UK paid pilot moved through evaluation, and a US Tier-1 AI voice-protection opportunity passed the best-and-final-offer phase. After quarter-end, Norwood announced A$695,000 of firm convertible-note commitments, with notes at 10% interest, a 1.9 cent conversion price and maturity on 30 June 2027.

XPON Technologies: Datisan Sale Reshapes the Balance Sheet

XPON's sale of Datisan to Incubeta Australia closed on 30 September 2026. The $8.1 million of initial consideration comprised a $5.5 million completion payment and a $2.6 million working capital adjustment, with a further earn-out of up to $2.0 million tied to gross profit targets for the 12 months ending 31 December 2026. XPON estimates a gain of about $9 million excluding the earn-out.

The sale removed $3.0 million of receivables and $6.4 million of payables. XPON repaid its $800k loan and $57k of accrued interest on 1 October 2026. Quarterly receipts were $2.334 million, operating cash flow was an outflow of $71k, and cash rose from $2.788 million to $8.412 million. The release recorded a cash position of $6.95 million on 28 October. Staff costs of $1.282 million were the largest payment line, and related-party payments totalled $162k.

Audeara: Revenue Growth and a Licensing Milestone

Audeara's Australian wholesale revenue rose 39.2% to $525,390, and AUA Technology revenue rose 193.2% to $62,195. Customer receipts fell 13.0% to $617k, which the company attributed to purchase order timing. Net operating cash outflow was $1.292 million compared with $795k in June, reflecting an inventory build ahead of pending AUA Technology orders. Staff payments rose 36.4% to $712k, while research and development payments fell 29.5% to $79k.

The two licensing programs in production carry initial purchase orders of approximately A$31k. Audeara raised $755,000 in the first tranche of a $1.26 million placement at $0.033 per share, with about $505,000 in a second tranche subject to approval at the 24 November 2026 AGM. Cash closed at $247k, and an OTCID quotation process began on 14 September. Clinico's introductory Auracast orders of approximately A$164,000 were reported as fulfilled and shipped on 19 October 2026.

How the Three Reports Compare

The reports differ in scale and source of cash. Norwood combined higher receipts with grant income, XPON's cash movement came from the Datisan disposal, and Audeara's came from a placement tranche and borrowings. Quarterly customer receipts were A$808,000 at Norwood, $2.334 million at XPON and $617k at Audeara, and the quarter-end cash balances were A$14,000, $8.412 million and $247k respectively. Net operating cash flow was an inflow of A$103,000 at Norwood, an outflow of $71k at XPON and an outflow of $1.292 million at Audeara.